SYHX2008

DRUG2 trials

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Conditions

AcromegalyDiagnosed With Acromegaly, Currently in the Active Stage of the Disease

Phase 2

A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly

CompletedNCT07814651

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Acromegaly

Start: 2024-04-16End: 2026-04-23Updated: 2026-09-11

Phase 3

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly

Not yet recruitingNCT07623824

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Diagnosed With Acromegaly, Currently in the Active Stage of the Disease

Start: 2026-05-31End: 2029-12-30Target: 154Updated: 2026-06-03